Literature DB >> 28533245

Clonal Dissemination of OXA-232 Carbapenemase-Producing Klebsiella pneumoniae in Neonates.

Dandan Yin1, Dong Dong2,3, Ke Li4, Lei Zhang1, Jianliang Liang1, Yang Yang2, Nana Wu1, Yiyan Bao1, Chuanqing Wang5, Fupin Hu6,3.   

Abstract

Five OXA-232 carbapenemase-producing Klebsiella pneumoniae isolates, belonging to the pandemic clone sequence type 15 (ST15), were isolated from neonates and coproduced blaCTX-M-15 and blaSHV-1 genes. All isolates were resistant to ertapenem (MICs of >32 μg/ml) and meropenem (MICs of 4 to 8 μg/ml) and susceptible or intermediate to imipenem (MICs of 1 to 2 μg/ml). The blaOXA-232 gene was located on a ColE-type transformable plasmid of 6,141 bp. To the best of our knowledge, this is the first report of OXA-232 carbapenemase among clinical isolates in China.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Klebsiella pneumoniae; OXA-232; ST15; clonal dissemination; neonates

Mesh：

Substances：

Year:  2017        PMID： 28533245      PMCID： PMC5527636          DOI： 10.1128/AAC.00385-17

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  18 in total

1.  Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR.

Authors:  F Javier Pérez-Pérez; Nancy D Hanson
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

2.  NDM-1, OXA-48 and OXA-181 carbapenemase-producing Enterobacteriaceae in Sultanate of Oman.

Authors:  L Dortet; L Poirel; F Al Yaqoubi; P Nordmann
Journal:  Clin Microbiol Infect       Date:  2012-03-08       Impact factor: 8.067

3.  Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006-2007.

Authors:  Mariana Castanheira; Lalitagauri M Deshpande; Dilip Mathai; Jan M Bell; Ronald N Jones; Rodrigo E Mendes
Journal:  Antimicrob Agents Chemother       Date:  2010-12-28       Impact factor: 5.191

4.  OXA-163, an OXA-48-related class D β-lactamase with extended activity toward expanded-spectrum cephalosporins.

Authors:  Laurent Poirel; Mariana Castanheira; Amélie Carrër; Carla Parada Rodriguez; Ronald N Jones; Jorgelina Smayevsky; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2011-03-21       Impact factor: 5.191

Review 5.  OXA-48-like carbapenemases: the phantom menace.

Authors:  Laurent Poirel; Anaïs Potron; Patrice Nordmann
Journal:  J Antimicrob Chemother       Date:  2012-04-11       Impact factor: 5.790

Review 6.  Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions.

Authors:  L S Tzouvelekis; A Markogiannakis; M Psichogiou; P T Tassios; G L Daikos
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

7.  Genetic and biochemical characterisation of OXA-232, a carbapenem-hydrolysing class D β-lactamase from Enterobacteriaceae.

Authors:  Anaïs Potron; Emilie Rondinaud; Laurent Poirel; Olivier Belmonte; Sophie Boyer; Sabine Camiade; Patrice Nordmann
Journal:  Int J Antimicrob Agents       Date:  2013-01-08       Impact factor: 5.283

8.  Whole-genome assembly of Klebsiella pneumoniae coproducing NDM-1 and OXA-232 carbapenemases using single-molecule, real-time sequencing.

Authors:  Yohei Doi; Tracy H Hazen; Matthew Boitano; Yu-Chih Tsai; Tyson A Clark; Jonas Korlach; David A Rasko
Journal:  Antimicrob Agents Chemother       Date:  2014-07-28       Impact factor: 5.191

9.  Emergence of clinical Klebsiella pneumoniae producing OXA-232 carbapenemase in Singapore.

Authors:  J W P Teo; A Kurup; R T P Lin; K T Hsien
Journal:  New Microbes New Infect       Date:  2013-09-18

10.  OXA-181-producing Klebsiella pneumoniae establishing in Singapore.

Authors:  Michelle N D Balm; Grace Ngan; Roland Jureen; Raymond T P Lin; Jeanette W P Teo
Journal:  BMC Infect Dis       Date:  2013-02-01       Impact factor: 3.090
View more
  22 in total

1.  Resistance reported from China antimicrobial surveillance network (CHINET) in 2018.

Authors:  Fupin Hu; Yan Guo; Yang Yang; Yonggui Zheng; Shi Wu; Xiaofei Jiang; Demei Zhu; Fu Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-09-02       Impact factor: 3.267

2.  Comparative Evaluation of Four Phenotypic Methods for Detection of Class A and B Carbapenemase-Producing Enterobacteriaceae in China.

Authors:  Menglan Zhou; Danchen Wang; Timothy Kudinha; Qiwen Yang; Shuying Yu; Ying-Chun Xu
Journal:  J Clin Microbiol       Date:  2018-07-26       Impact factor: 5.948

Review 3.  The Global Ascendency of OXA-48-Type Carbapenemases.

Authors:  Johann D D Pitout; Gisele Peirano; Marleen M Kock; Kathy-Anne Strydom; Yasufumi Matsumura
Journal:  Clin Microbiol Rev       Date:  2019-11-13       Impact factor: 26.132

4.  Identification of a Novel Ceftazidime-Avibactam-Resistant KPC-2 Variant, KPC-123, in Citrobacter koseri Following Ceftazidime-Avibactam Treatment.

Authors:  Lin Wang; Weiyi Shen; Rong Zhang; Jiachang Cai
Journal:  Front Microbiol       Date:  2022-06-20       Impact factor: 6.064

5.  The Characterization of OXA-232 Carbapenemase-Producing ST437 Klebsiella pneumoniae in China.

Authors:  Xingbei Weng; Qiucheng Shi; Sheng Wang; Yubo Shi; Dinghe Sun; Yunsong Yu
Journal:  Can J Infect Dis Med Microbiol       Date:  2020-07-08       Impact factor: 2.471

6.  Dissemination of Carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) Among Carbapenem-Resistant Enterobacteriaceae Isolated From Adult and Children Patients in China.

Authors:  Renru Han; Qingyu Shi; Shi Wu; Dandan Yin; Mingjia Peng; Dong Dong; Yonggui Zheng; Yan Guo; Rong Zhang; Fupin Hu
Journal:  Front Cell Infect Microbiol       Date:  2020-07-03       Impact factor: 5.293

7.  In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing Klebsiella pneumoniae.

Authors:  Wenxia Zhang; Yan Guo; Jiayin Li; Yiyuan Zhang; Yang Yang; Dong Dong; Demei Zhu; Ping He; Fupin Hu
Journal:  Antimicrob Resist Infect Control       Date:  2018-11-21       Impact factor: 4.887

8.  Resistance phenotype and clinical molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae among pediatric patients in Shanghai.

Authors:  Dongxing Tian; Fen Pan; Chun Wang; Yan Sun; Hong Zhang
Journal:  Infect Drug Resist       Date:  2018-10-24       Impact factor: 4.003

9.  Active Surveillance of Carbapenemase-Producing Organisms (CPO) Colonization With Xpert Carba-R Assay Plus Positive Patient Isolation Proves to Be Effective in CPO Containment.

Authors:  Menglan Zhou; Timothy Kudinha; Bin Du; Jinmin Peng; Xiaojun Ma; Yang Yang; Ge Zhang; Jingjia Zhang; Qiwen Yang; Ying-Chun Xu
Journal:  Front Cell Infect Microbiol       Date:  2019-05-14       Impact factor: 5.293

10.  Evaluation of modified carbapenem inactivation method for suspected carbapenemase among Enterobacteriaceae clinical isolates.

Authors:  Beiwei Yu; Dong Dong; Mingxia Wang; Yan Guo; Dandan Yin; Fupin Hu
Journal:  Oncotarget       Date:  2018-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.